Emily B. Einstein

2.9k total citations · 4 hit papers
32 papers, 1.8k citations indexed

About

Emily B. Einstein is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology. According to data from OpenAlex, Emily B. Einstein has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 13 papers in Epidemiology and 9 papers in Pharmacology. Recurrent topics in Emily B. Einstein's work include Opioid Use Disorder Treatment (13 papers), Substance Abuse Treatment and Outcomes (11 papers) and Cannabis and Cannabinoid Research (6 papers). Emily B. Einstein is often cited by papers focused on Opioid Use Disorder Treatment (13 papers), Substance Abuse Treatment and Outcomes (11 papers) and Cannabis and Cannabinoid Research (6 papers). Emily B. Einstein collaborates with scholars based in United States, Australia and Belgium. Emily B. Einstein's co-authors include Wilson M. Compton, Nora D. Volkow, Christopher M. Jones, Beth Han, Eric Wargo, Emily Jones, Marina R. Picciotto, Grant Baldwin, Nichole M. Neugebauer‎ and Yann S. Mineur and has published in prestigious journals such as JAMA, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Emily B. Einstein

30 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention and Treatment of Opioid Misuse and Addiction

2018 419 citations Nora D. Volkow, Emily B. Einstein et al. JAMA Psychiatry profile →
Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016

2018 283 citations Christopher M. Jones, Emily B. Einstein et al. profile →
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults

2021 194 citations Beth Han, Wilson M. Compton et al. JAMA Psychiatry profile →
Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021

2023 91 citations Christopher M. Jones, Beth Han et al. JAMA Network Open profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Emily B. Einstein	752	566	337	312	295	32	1.8k
Gavin Bart	797 1.1×	702 1.2×	547 1.6×	320 1.0×	287 1.0×	70	1.9k
Karen Drexler	696 0.9×	632 1.1×	587 1.7×	205 0.7×	185 0.6×	54	1.9k
Einat Peles	837 1.1×	786 1.4×	366 1.1×	433 1.4×	288 1.0×	109	2.6k
Jermaine D. Jones	1.0k 1.4×	630 1.1×	559 1.7×	267 0.9×	242 0.8×	79	2.2k
Hilary S. Connery	973 1.3×	841 1.5×	274 0.8×	403 1.3×	183 0.6×	62	2.0k
Paolo Mannelli	579 0.8×	707 1.2×	460 1.4×	194 0.6×	273 0.9×	91	2.1k
Miriam Adelson	1.0k 1.3×	940 1.7×	496 1.5×	521 1.7×	351 1.2×	113	2.9k
Laura F. McNicholas	1.1k 1.5×	761 1.3×	306 0.9×	341 1.1×	153 0.5×	26	1.6k
Theresa Winhusen	764 1.0×	861 1.5×	484 1.4×	477 1.5×	216 0.7×	132	2.6k
Anna Lembke	713 0.9×	435 0.8×	122 0.4×	193 0.6×	180 0.6×	69	2.6k

Countries citing papers authored by Emily B. Einstein

Since Specialization

Citations

This map shows the geographic impact of Emily B. Einstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily B. Einstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily B. Einstein more than expected).

Fields of papers citing papers by Emily B. Einstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily B. Einstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily B. Einstein. The network helps show where Emily B. Einstein may publish in the future.

Co-authorship network of co-authors of Emily B. Einstein

This figure shows the co-authorship network connecting the top 25 collaborators of Emily B. Einstein. A scholar is included among the top collaborators of Emily B. Einstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily B. Einstein. Emily B. Einstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Beth, Christopher M. Jones, Nora D. Volkow, et al.. (2025). Prevalence of cannabis consumption methods among people with medically recommended and nonmedical cannabis use in the United States. Addiction. 120(5). 962–974.

Han, Beth, Christopher M. Jones, Nora D. Volkow, et al.. (2025). Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years. JAMA Psychiatry. 82(6). 572–572. 7 indexed citations

Jones, Christopher M., Kun Zhang, Beth Han, et al.. (2024). Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021. JAMA Psychiatry. 81(8). 789–789. 10 indexed citations

Han, Beth, Christopher M. Jones, Emily B. Einstein, Deborah Dowell, & Wilson M. Compton. (2024). Prescription Opioid Use Disorder Among Adults Reporting Prescription Opioid Use With or Without Misuse in the United States. The Journal of Clinical Psychiatry. 85(3). 4 indexed citations

Jones, Christopher M., Beth Han, Grant Baldwin, Emily B. Einstein, & Wilson M. Compton. (2023). Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021. JAMA Network Open. 6(8). e2327488–e2327488. 91 indexed citations breakdown →

Han, Beth, Emily B. Einstein, & Wilson M. Compton. (2023). Patterns and Characteristics of Nicotine Dependence Among Adults With Cigarette Use in the US, 2006-2019. JAMA Network Open. 6(6). e2319602–e2319602. 16 indexed citations

Compton, Wilson M., Emily B. Einstein, Eric Wargo, Aria Davis Crump, & Will M. Aklin. (2023). Racial inequities and addiction research. Drug and Alcohol Dependence. 251. 110940–110940. 4 indexed citations

Hjorthøj, Carsten, Wilson M. Compton, Marie Starzer, et al.. (2023). Association between cannabis use disorder and schizophrenia stronger in young males than in females. Psychological Medicine. 53(15). 7322–7328. 42 indexed citations

Han, Beth, et al.. (2023). Pregnancy and Postpartum Drug Overdose Deaths in the US Before and During the COVID-19 Pandemic. JAMA Psychiatry. 81(3). 270–270. 40 indexed citations

10.

Han, Beth, Carlos Blanco, Emily B. Einstein, & Wilson M. Compton. (2022). Mental health conditions and receipt of mental health care by illicit lysergic acid diethylamide (LSD) use status among young adults in the United States. Addiction. 117(6). 1794–1800. 11 indexed citations

11.

Compton, Wilson M., Emily B. Einstein, & Christopher M. Jones. (2022). Exponential increases in drug overdose: Implications for epidemiology and research. International Journal of Drug Policy. 104. 103676–103676. 4 indexed citations

12.

Huntley, Kristen, et al.. (2021). Advancing emergency department–initiated buprenorphine. SHILAP Revista de lepidopterología. 2(3). e12451–e12451. 5 indexed citations

13.

Han, Beth, Christopher M. Jones, Emily B. Einstein, & Wilson M. Compton. (2021). Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US. JAMA Network Open. 4(10). e2129409–e2129409. 26 indexed citations

14.

Mineur, Yann S., et al.. (2014). Expression of the 5-HT1A Serotonin Receptor in the Hippocampus Is Required for Social Stress Resilience and the Antidepressant-Like Effects Induced by the Nicotinic Partial Agonist Cytisine. Neuropsychopharmacology. 40(4). 938–946. 28 indexed citations

15.

Neugebauer‎, Nichole M., et al.. (2013). Morphine dependence and withdrawal induced changes in cholinergic signaling. Pharmacology Biochemistry and Behavior. 109. 77–83. 37 indexed citations

16.

Maier, Donna L., Min Ding, Emily B. Einstein, et al.. (2011). Pre-clinical validation of a novel alpha-7 nicotinic receptor radiotracer, [3H]AZ11637326: Target localization, biodistribution and ligand occupancy in the rat brain. Neuropharmacology. 61(1-2). 161–171. 20 indexed citations

17.

Holmes, Fiona E., Tiina P. Iismaa, Emily B. Einstein, et al.. (2011). Galanin negatively modulates opiate withdrawal via galanin receptor 1. Psychopharmacology. 220(3). 619–625. 14 indexed citations

18.

Mineur, Yann S., Emily B. Einstein, Patricia A. Seymour, et al.. (2011). α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties. Behavioural Pharmacology. 22(4). 291–299. 42 indexed citations

19.

Einstein, Emily B., Carlyn A. Patterson, Kathleen A. Regan, et al.. (2010). Somatostatin Signaling in Neuronal Cilia Is Criticalfor Object Recognition Memory. Journal of Neuroscience. 30(12). 4306–4314. 98 indexed citations

20.

Picciotto, Marina R., Christian Brabant, Emily B. Einstein, Helen M. Kamens, & Nichole M. Neugebauer‎. (2009). Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors. Brain Research. 1314. 206–218. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact